
Venture capital
ShangBay Capital
Palo Alto venture capital firm investing in medical device, biotechnology and healthcare technology companies through venture equity, with a large portfolio and several exits.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is ShangBay Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds ShangBay Capital joined, from press and the firm’s own posts.
1 round in the last 12 months
Round sizes, ShangBay Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company ShangBay Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet ShangBay Capital
Events where ShangBay Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
ShangBay Capital is based in Palo Alto, United States.
6 fund vehicles are on public registers (SEC adviser filings), including SHANGBAY CAPITAL III, LLC, SHANGBAY CAPITAL OPPORTUNITY, LLC and SHANGBAY CAPITAL II, LLC.
Sectors: Medtech, Biotech, Health tech. From the firm’s own website.
Backs founders building disruptive companies that tackle high, unmet clinical needs with novel ideas. Leverages a leadership team's deep ties to strategics and experienced innovators to help founders meet large market needs and generate favorable returns. From the firm’s own website.
ShangBay Capital lists 70 portfolio companies on its website, including CERIBELL, LUCIRA HEALTH, ARRINEX, APEXIGEN and BERKELEY LIGHTS.
Firms whose websites list some of the same companies include Agent Capital, RA Capital and Gilmartin Capital.
Know before ShangBay Capital’s next round is announced.
PRO tracks ShangBay Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.